Wait time and Vision and Health Problems in Adults Expecting Corneal Transplantation at a Hospital in Montreal, Canada M Alizadeh-Ebadi MD, H Boisjoly.

Slides:



Advertisements
Similar presentations
Therapeutic Penetrating Keratoplasty in Fungal Keratitis: Prospective Study Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author.
Advertisements

Sérgio Kwitko, Tiago Lansini, Andressa P Stolz, Diane R Marinho Authors have no financial interest in the subject matter of this poster.
The authors have no financial disclosures relevant to the topic.
Case management for multimorbid patients Nathalie Versnel, MSc. François Schellevis, MD, PhD Giel Nijpels, MD, PhD Caroline Baan, PhD.
Katsuya Yamazoe, MD, Takefumi Yamaguchi, MD, Kazuki Hotta, MD, Yoshiyuki Satake, MD, Kenji Konomi, MD, Seika Den, MD, Jun Shimazaki, MD Presented by: Abdulrahman.
Relationship Between Donor Graft Cell Count and Visual Outcome in DSAEK Patients Authors Silvin Bakalian MD PhD, Johanna Choremis MD FRCSC, Michele Mabon.
Jeffrey J. Ing, MD, FACS, (Delta Eye Medical Group, Loma Linda University School of Medicine, Department of Ophthalmology) Thanh T. Nguyen, OD (Delta Eye.
Refractive Effects of Lamellar Keratectomy/Debridement for Corneal Surface Disorders Pre-Cataract Surgery Haresh Ailani MD, 1 Ira J. Udell MD, 1 Jules.
Long-Term Outcome of Corneal Transplant Surgery in Pediatric Patients with Keratoconus Anna Djougarian, MD Hofstra / North Shore-LIJ Medical Center Gerald.
CHAPTER 2 CORNEAL TRANSPLANTATION
Partnerships for Success: Corneal Transplant in the 21st Century Breakout Session A Presenters: Christopher Blanton, MD Medical Director, Ocular Services,
® Introduction Mental Health Predictors of Pain and Function in Patients with Chronic Low Back Pain Olivia D. Lara, K. Ashok Kumar MD FRCS Sandra Burge,
Blepharitis and Dry eyes in Aromatase Inhibitor Users Kiran Turaka, M.D. Kristin M. Hammersmith, M.D. Jennifer M. Nottage, M.D. Christopher J. Rapuano,
Elvin H. Yildiz, Elisabeth J. Cohen, Ajoy S. Virdi, Kristin M. Hammersmith, Peter R Laibson, and Christopher J. Rapuano Cornea Service, Wills Eye Institute,
Hemi-Automated Lamellar Keratoplasty (HALK) Leonard Yuen, MD MPH MRCOphth Jodhbir Mehta, FRCS FRCOphth Li Lim, FRCOphth Donald Tan, FRCS FRCOphth SINGAPORE.
Blepharitis and Dry eyes in Aromatase Inhibitor Users
Bryan Y Kim 1, Shintaro Kanayama MD PhD 1, Tueng T Shen MD PhD 1, Thomas E Gillette MD 2 1 University of Washington Department of Ophthalmology, 2 Eye.
Dr. K.S.SIDDHARTHAN Aravind Eye Hospital Coimbatore
Somasheila I. Murthy, Prashant Garg, Pravin K. Vaddavalli
1.PATIENTS’ CHARACTERISTICS Table 1.1: Age distributions.
The Second Report of The National cataract Surgery Registry PATIENTS’ CHARACTERISTICS Table 1.1: Age Distributions.
Table 2.1.1: Number of Cornea Transplantation and Transplant Rate per million population (pmp), Year No.
Evaluation of Corneal Parameters and Spherical Aberration After DSAEK Measured with Pentacam System Orkun Muftuoglu, Pawan Prasher, R. Wayne Bowman, Steven.
Evaluation of Interface Reflectivity and Corneal Aberrations following DSAEK Hamid Khakshoor, MD Professor of Ophthalmology Mashhad University of Medical.
Neeti Parikh, MD Fuxiang Zhang, MD Department of Ophthalmology Henry Ford Hospital A Comparison Of Patient Satisfaction With Modified Monovision Versus.
Table 2.1.1: New Transplant Rate per million population (pmp), Year New transplants
Vision related quality of life in persons with Dry eye syndrome using the 25 item National eye Institute visual function questionnaire S.P. Mahesh MD Janine.
Blepharitis and Dry eyes in Aromatase Inhibitor Users Kiran Turaka, M.D. Kristin M. Hammersmith, M.D. Jennifer M. Nottage, M.D. Christopher J. Rapuano,
Lori Lombardi MD, Mark A. Terry MD, Neda Shamie MD, Anand K. Shah MD, Daniel J. Friend MS *Dr. Terry has a financial interest in Bausch & Lomb instruments.
Deep anterior lamellar keratoplasty (DALK) in Tohoku University, Japan T Hariya MD, A Kubota MD PhD, M Uematsu MD, S Yokokura MD PhD,K Nishida MD PhD,
Outcome of therapeutic keratoplasty in fungal keratitis Sonika Gupta, MS Assistant Professor, GMCH, Chandigarh, India Author has no financial interest.
Glaucoma and Penetrating Keratoplasty : Incidence, Risk Factors, and Outcomes Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author.
Visual Outcomes After Temporary Keratoprosthesis Kristin C. Bains, MD Robert Phillips, MD The authors have no financial interest in the subject matter.
Problem: Studies suggest that primary care physician-patient encounters are characterized by competing demands that force clinicians to prioritize and.
Indications for and Outcomes of Therapeutic Penetrating Keratoplasty Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author has no.
Endothelial Dystrophy Association with Hyperopia Glenn W. Thompson, M.D. Timothy P. Page, M.D. Authors have no financial interest.
Deep anterior lamellar keratoplasty in children World Cornea Congress April 2010 Boston, MA Asim Ali, MD, FRCSC University of Toronto Hospital for Sick.
Elisabeth CA Macdonald, Paul A Cauchi, Augusto Azuara-Blanco, Barny Foot Authors have no financial interest BOSU.
Endothelial Keratoplasty in Patients With an Anterior Chamber Intraocular Lens: A Montreal Experience Georges M. Durr, MD 1,2 Johanna Choremis, MD, FRCSC.
Pattern of Pain and Analgesic use after Collagen Crosslinking for Progressive Keratoconus Ramon Coral Ghanem, MD, PhD. Renan Ferreira Oliveira, MD. Vinicius.
Clinical outcome of DALK in Keratoconus – A one year follow up
Tiago Lansini, MD ; Sergio Kwitko, PhD Authors have no financial interest in the subject matter of this poster.
Combined cataract surgery and endoscopic cyclophotocoagulation in patients with glaucoma without prior incisional glaucoma surgery Matthew P. Traynor,
DEVELOPING AND VALIDATION OF AN ARABIC VERSION OF THE VISUAL FUNCTIONING INDEX VF14 FOR CATARACT PATIENTS Abdulrahman Al-Muammar, MD, FRCSC King Abdul.
J. Brian Foster, MD No Financial Disclosures
Incidence of Cataract Extraction After Corneal Transplantation in Young and Middle-Aged Patients Revathi Naadimuthu, MD Gerald W. Zaidman, MD Brandon Mirochnik,
Daniel D. Hayes, MD1; Carolyn Y. Shih, MD1; David C
Risk Factors and Outcomes of Donor Lenticule Dislocation Following DSEK Pravin K Vaddavalli MD, Suntia Chaurasia MD, Muralidhar Ramappa MD, Prashant Garg.
Deep Anterior Lamellar Keratoplasty (DALK) Vs Penetrating Keratoplasty (PK) in patients with Keratoconus (KC). Dr. K.S.SIDDHARTHAN Aravind Eye Hospital.
Corneal Tattooing with Amniotic Membrane Woo Chan Park M.D., Won Yeol Ryu M.D. Dept. of Ophthalmology, College of Medicine, Dong-A University Busan, Korea.
Elmira Baghdasaryan1,2, M.D. Sophie X. Deng1, M.D., Ph.D.
Yonca Aydin Akova MD, Leyla Erkanli Asena MD
UC Davis Long-Term Outcomes of the Boston Type I Keratoprosthesis Jennifer Li, M.D., Mark Greiner, M.D. Ana Carolina Vieira, M.D. Mark Mannis, M.D. University.
Descemet’s Stripping Endothelial Keratoplasty (DSEK) in patients with prior Trabeculectomy or Tube shunt surgery. Thadani S.M. Fynn-Thompson N. Authors.
Cost-Effectiveness of the Type II Boston Keratoprosthesis Jared D. Ament, MD, MPH, Tomasz P. Stryjewski, BS, Siddharth Pujari, PhD, George Papaliodus,
Annick Mwilambwe, MD 1, Walter Wittich, MSc 2,3, Ellen E. Freeman, PhD 1,4 1 Department of Ophthalmology, University of Montreal, 2 Department of Neurology.
"Mix and Match" approach implantation
Contact: Kamran Rahmatnejad, MD
Factors Influencing Patient Satisfaction in a Glaucoma Population
World Cornea Congress VI April 7-9, 2010
DSAEK using corneas with previous LASIK
Endothelial keratoplasty in failed grafts
Kyoto Prefectural University of Medicine
Early Experience with Descemet’s Stripping Automated Endothelial Keratoplasty Combined with Phacoemulsification: Clinical and Refractive Outcome University.
Hong A, Boehlke CS, Afshari NA, Kim T Duke University Medical Center
A presentation to: Meeting name Date
Long term Results of Endothelial Keratoplasty in patients with failed penetrating Keratoplasty Maoz D. Amiran, MD, Raneen Shehadeh-Mashor, MD, Marie Eve.
Traumatic Wound Dehiscence After Corneal Keratoplasty
Role of HSV Infection in the Histopathology of Failed DSAEK
Presentation transcript:

Wait time and Vision and Health Problems in Adults Expecting Corneal Transplantation at a Hospital in Montreal, Canada M Alizadeh-Ebadi MD, H Boisjoly MD MPH, F Djafari MD MSc, E Freeman PhD, J Lachaine PhD, I Brunette MD Boston, MA April 7-9, 2010 The authors have no financial interest in the subject matter of this poster. 1

Purpose Wait time for corneal transplantation still is a problem in Montreal, Canada. Anticipated results: Subjects waiting for PK or DSAEK corneal grafts have worse visual acuity, lower VF-14 scores, more pain or discomfort, more restriction in physical and social activities; they are more depressed, fall more, and use health care services more frequently than subjects with normal vision not scheduled for eye surgery. 2

Cross-sectional, Case-Control designed with age/gender group-matching, single institution study. Cases are patients on corneal transplant waiting list as of January 31, 2009 at Maisonneuve-Rosemont Hospital in Montreal, Canada. Three groups of consecutive consenting adults aged 50 years and older were enrolled (n total=75): PK Candidates (n=25) DSAEK Candidates (n=25) Controls with good vision and no planned surgery (n=25) Average age of patients was 73 and 2/3 were females. 94% of participants were Caucasian. Materials 3

Materials Outcome measures (1) Visual health measures: Daily life visual function VF-14 questionnaire. [10,18,19] Ocular symptom score including pain and discomfort: modified CSS (Cataract Symptom Scale) questionnaire. [20] BCVA for distance was measured with ETDRS chart. [21] 4

Materials Outcome measures (2) General health measures: Geriatric Depression Scale–(GDS-15). [22-25] Medical Outcomes Study, 36-item Short-Format Health Survey (SF-36) questionnaire. [26-28] Medical comorbidities (14 questions about frequent health problems). [29] Number of falls and burns during the past year. [31] 5

Materials Outcome measures (3) Wait time measures: Duration in days from completion of the surgery admission form to the time of the study; review of medical record. Acceptability of wait time; question. Patient expectation measures: Patient expected wait time at the time of study; question. Estimation of perceived utility of the surgery: EQ-5D (also referred as EuroQol) questionnaire to estimate utility. [33-35] 6

Wait time results Mean accumulated wait time was 20.0±15.6 months. Perceived wait time was 26.7±22.9 months. 58% found this unacceptable. Transplant candidates felt their wait time should be around 7.9±5.2 months. 7

Table 1: Pre operative Corneal Graft Diagnoses DiagnosisDSAEK (n=25)PK (n=25) Fuchs’ Endothelial dystrophy 80% (20)8% (2) Bullous Keratopathies20% (5)48% (12) Failed Penetrating Keratopathy 0% (0)20% (5) HSV and interstitial Keratitis 0% (0)12% (3) Traumatic Keratitis0% (0)4% (1) Keratoconus0% (0)4% (1) Fungal Keratitis0% (0)4% (1) 8

On the Snellen chart: 0.1 logMAR corresponds to 6/7.5, 0.2 to 6/9.5, 0.4 to 6/15, 0.6 to 6/24, 1.2 to 6/95, and 1.3 to 6/120 Table 2: Visual Acuities Visual Acuity Mean LogMAR ± SD GroupP value CORNEAL GRAFT (n=50) CONTROL (n=25) Worst Eye presenting VA1.3 ± ± 0.1<0.001 Worst Eye PH VA1.2 ± ± 0.1<0.001 Best Eye presenting VA0.6 ± ± 0.1<0.001 Best Eye PH VA0.4 ± ± 0.1<0.001 Surgical Eye VA Mean LogMAR ± SD Presenting: 1.3 ± 0.5 Pin hole: 1.2 ± 0.5 9

Table 3: Visual Function Questionnaires VF-14: Visual Function-14 item, CSS-5: Cataract Symptom Scale-5 item Questionnaire (range of possible scores) Mean Score ± SD GroupP value CORNEAL GRAFT (n=50) CONTROL (n=25) Actual VF-14 (0-100)57.8 ± ± 3.8<0.001 CSS-5 (0-15)4.4 ± ± 0.3<0.001 Vision loss last month (0-3)0.9 ± ± Discomfort in eyes last month (0-3)0.8 ± ± 1.0NS Pain in eyes last month (0-3)0.6 ± ± Problems with vision % (n)Little or none16 (8)100 (25)<0.001 Moderate or great deal84 (42)0 (0) Satisfaction with vision % (n)Satisfied18 (9)92 (23)<0.001 Dissatisfied82 (41)8 (2) 10

Table 4: Quality of Life Questionnaires SF-36 (Short Format health survey), EQ5D (EuroQol) Questionnaire (range of possible scores) Mean Score ± SD GroupP value CORNEAL GRAFT (n=50) CONTROL (n=25) SF-36 (0-100)Physical health 48.0 ± ± 10.4 NS Mental health 50.4 ± ± Comorbidities (0-42) 7.2 ± ± 5.4 NS EQ5D (0-1) 0.8 ± ± Depression (0-15)2.5 ± ±

Discussion In year 2009 and prior to that, the wait time for corneal transplant was unacceptably long. The wait time presented here does not reflect the period that new referrals waited to be seen by the cornea specialist. The results of this pilot study will serve to calculate sample sizes for a future multicenter study on wait time for corneal transplantation in Canada. These results helped in advocacy to improve access to donor corneas. The government of Quebec has taken steps to overcome the wait time issue for corneal transplantation. Currently, the wait time is estimated to be between 3-6 months. 12